NeuroStar has received FDA clearance as a first-line treatment for adolescents with depression, making it the first and only TMS therapy cleared as an adjunct treatment for patients ages 15 and older!

  • posted: Apr. 22, 2024

https://www.globenewswire.com/en/news-release/2024/03/25/2851611/0/en/NeuroStar-Advanced-Therapy-Receives-FDA-Clearance-as-a-First-Line-Add-On-Treatment-for-Adolescents-with-Depression.html